Skip to main content
Smart Investors Daily
AM

OTC · AMBBY

Ambu A/S

Healthcare · Medical - Devices

$13.20

Up+$1.10 (+9.09%)

Updated Nov 5, 2026, 12:48 PM

SID Score

4.8/10

Composite research score

Smart Money

46/100

Neutral

Market cap
3.34B
P/E ratio
39.19
Dividend yield
0.48%
52-week range
— – —
Volume
100
Avg. volume
234

Price performance · AMBBY

AMBBY price history

1M range · 0 trading sessions · Daily adjusted prices

AMBBY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest AMBBY news

The latest Smart Investors Daily articles mentioning AMBBY.

AMBBY research

Overview

Company profile and research snapshot.

Company profile

AMBU A S UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
AMBBY recent ratings
DateFirmRatingTarget
Sep 23, 2026ROTHSCHILD & CO REDBURNNeutral—
Aug 28, 2026DNB CARNEGIEBuy—
Jul 9, 2026ROTHSCHILD & CO REDBURNNeutral—
Jul 8, 2026ROTHSCHILD & CO REDBURNNeutral—
Jul 8, 2026DNB CARNEGIEBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 27, 2026

Is Ambu (CPSE:AMBU B) A Bargain Or Fully Priced?

Ambu has seen its share price move around sharply over recent years, which raises a simple question for you as an investor. Is the current price around these levels really aligned with the cash the business is expected to generate over time, or has sentiment moved further than its cash flows justify? Over the past 5 years the stock has fallen 54.7%, which puts the focus squarely on whether the cash Ambu can produce in future supports even the current valuation. The company’s value story now...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.